Compare CPF & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CPF | INSP |
|---|---|---|
| Founded | 1954 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 997.1M | 1.2B |
| IPO Year | 2011 | 2018 |
| Metric | CPF | INSP |
|---|---|---|
| Price | $39.32 | $50.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 16 |
| Target Price | $37.00 | ★ $94.00 |
| AVG Volume (30 Days) | 124.8K | ★ 858.3K |
| Earning Date | 04-29-2026 | 05-04-2026 |
| Dividend Yield | ★ 3.39% | N/A |
| EPS Growth | 45.18 | ★ 179.43 |
| EPS | ★ 0.78 | N/A |
| Revenue | $51,817,000.00 | ★ $82,050,000.00 |
| Revenue This Year | N/A | $8.02 |
| Revenue Next Year | $4.62 | $8.11 |
| P/E Ratio | $50.47 | ★ N/A |
| Revenue Growth | 33.81 | ★ 62.18 |
| 52 Week Low | $26.08 | $38.91 |
| 52 Week High | $40.31 | $147.03 |
| Indicator | CPF | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 59.15 | 50.14 |
| Support Level | $37.60 | $48.30 |
| Resistance Level | $39.63 | $53.50 |
| Average True Range (ATR) | 0.92 | 2.22 |
| MACD | -0.06 | -0.38 |
| Stochastic Oscillator | 59.32 | 18.71 |
Central Pacific Financial Corp operates in the financial services sector in the United States. It is a full-service commercial bank offering a broad range of banking products and services, including accepting time and demand deposits and originating loans. Bank's deposits are insured by the Federal Deposit Insurance Corporation (FDIC) up to applicable limits. The bank is not a member of the Federal Reserve System. The company's loans include commercial loans, construction loans, commercial and residential mortgage loans, and consumer loans. The company derives income from interest and fees on loans, interest on investment securities, and fees received in connection with deposits and other services. It operates in single segment which is Banking operations.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.